Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria

CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213

Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research